Clinical Trial Update: Evaluation of Safety, Efficacy and Pharmacodynamic Effect of Bertilimumab in Patients With Bullous Pemphigoid [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating Bertilimumab in bullous pemphigoid. Results addressing safety, efficacy and pharmacodynamic effects were posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bullous Pemphigoid

Drugs mentioned

• Bertilimumab

Snippet

Sponsor: Alexion Pharmaceuticals, Inc. | Conditions: Pemphigoid, Bullous | Phase 2 | Status: COMPLETED | Results posted: 2025-11-26